博士論文

Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation

Icons representing 博士論文

Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation

Call No. (NDL)
UT51-2012-D284
Bibliographic ID of National Diet Library
023800201
Material type
博士論文
Author
Hideyuki Yoshida [著]
Publisher
[Hideyuki Yoshida]
Publication date
[2012]
Material Format
Paper
Capacity, size, etc.
1冊
Name of awarding university/degree
九州大学,博士 (医学)
View All

Notes on use

Note (General):

博士論文

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type
博士論文
Author/Editor
Hideyuki Yoshida [著]
Author Heading
吉田, 秀行 ヨシダ, ヒデユキ
Publication, Distribution, etc.
Publication Date
[2012]
Publication Date (W3CDTF)
2012
Extent
1冊
Alternative Title
低用量のpan-JAK阻害剤CP-690,550(tofacitinib)の投与はTh17の分化を促進させ実験的自己免疫性脳脊髄炎の発症を促進させる テイヨウリョウ ノ pan-JAK ソガイザイ CP-690550 (tofacitinib) ノ トウヨ ワ Th17 ノ ブンカ オ ソクシンサセ ジッケンテキ ジコ メンエキセイ ノウ セキズイエン ノ ハッショウ オ ソクシンサセル
Degree grantor/type
九州大学